Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsOpinionIndian pharma will benefit if a new US bill is passed

    Indian pharma will benefit if a new US bill is passed

    A proposed legislation could make it difficult for brand-name companies to delay the launch of generics and biosimilars

    Sundeep Khanna
    May 05, 2023 / 09:09 IST
    The only solution to consolidated buying power is for suppliers to refrain from selling at cutthroat rates, given the number of Indian pharma firms ready to supply at any price point. (Representative image)
    • PRO Panorama

      Moneycontrol Pro Panorama | Tech tensions

      Jan 5, 2026 / 03:36 PM IST

      For January 5 edition of Moneycontrol Pro Panorama: S Jaishankar’s diplomacy strengthens India-Bangladesh relations, India faces...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts